Secretary Leavitt sign
on letter
The Honorable Michael O. Leavitt
Secretary of Health and
Human Services
U.S. Department of Health and Human Services
200
Independence Avenue, SW
Washington, DC 20201
Dear Secretary
Leavitt,
We are writing you to urge you to renew the charter and fully
fund the
Department of Health and Human Services Chronic Fatigue
Syndrome
Advisory Committee (CFSAC). As you know, CFSAC is a federal
advisory
committee that provides evidence-based advice on the current state
of
research on chronic fatigue syndrome (CFS) and research
opportunities,
current and proposed diagnostic and treatment methods, and
the
development and implementation of programs to educate the public,
health
care professionals, and researchers about CFS research and
advances.
Chronic fatigue syndrome, also called chronic fatigue and
immune
dysfunction syndrome, is a complex and debilitating illness that
affects
the brain and multiple body systems. The Centers for Disease Control
and
Prevention estimates that more than one million American adults
and
teens have CFS, costing our nation an estimated $9.1 billion a year
in
lost productivity-not including medical costs. CFS warrants
serious
attention by the Department of Health and Human Services.
Meetings of the CFSAC provide a vital opportunity for experts
selected
by the Department to hear reports from, provide input to and
monitor
progress of the CDC, NIH, Health Resources and Services
Administration,
Food and Drug Administration and the Social Security
Administration. The
CFSAC's meetings also provide the patient community the
opportunity to
participate in these discussions and voice concerns through
public
testimony. Thus, CFSAC allows for greater transparency
and
accountability, helping to ensure that the most effective utilization
of
federal resources dedicated to CFS.
In 2004, the CFSAC presented
your office with 11 recommendations. While
you have yet to formally respond
to these and later recommendations
issued by the Committee, the Centers for
Disease Control and Prevention
and the National Institutes of Health have
implemented at least two of
the recommendations - notably NIH's July 2005
issuance of a Request for
Applications for CFS research and CDC's support of
a national CFS
awareness campaign.
The CFS Advisory Committee serves
an important forum for obtaining
information, providing input and monitoring
progress on federal
activities pertaining to CFS. It is essential the CFSAC
continue its
work so that we can continue our momentum. We urge you to renew
CFSAC's
charter before its September 5, 2006 date of expiration, to respond
to
the committee about the status of earlier recommendations and to
fully
support its continued
work.
Sincerely